18 F ‐Fluoro‐2‐Deoxyglucose Positron Emission Tomography/Computed Tomography Measures of Spatial Heterogeneity for Predicting Platinum Resistance of High‐Grade Serous Ovarian Cancer
Cancer Medicine · 2024
DOI: 10.1002/cam4.70287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Xin Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Ovarian Neoplasms, Fluorodeoxyglucose F18, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Foundation of Liaoning Provincial, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
The purpose of this study is to construct models for predicting platinum resistance in high‐grade serous ovarian cancer (HGSOC) derived from quantitative spatial heterogeneity indicators obtained from 18 F‐FDG PET/CT images.
Methods
A retrospective study was conducted on patients diagnosed with HGSOC. Quantitative indicators of spatial heterogeneity were generated using conventional features and Haralick texture features from both CT and PET images. Three groups of predictive models (conventional, heterogeneity, and integrated) were built. Each group's optimal model was the one with the highest area under curve (AUC). Postoperative immunohistochemical staining for Ki‐67 and p53 was conducted. The correlation between the heterogeneity indicators and scores for Ki‐67 and p53 was assessed by Spearman's correlation coefficient ( ρ ).
Results
A total of 286 patients (54.6 ± 9.3 years) were enrolled. And 107 spatial heterogeneity indicators were extracted. The optimal models for each group were obtained using the Gradient Boosting Machine (GBM) algorithm. There was an AUC of 0.790 (95% CI: 0.696, 0.885) in the conventional model for the validation set, and an AUC of 0.904 (95% CI: 0.842, 0.966) in the heterogeneity model for the validation set. The integrated model achieved the highest predictive performance, with an AUC value of 0.928 (95% CI: 0.872, 0.984) for the validation set. Spearman's correlation showed that HU_Kurtosis had the strongest correlation with p53 scores with ρ = 0.718, while cluster site entropy had the strongest correlation with Ki‐67 scores with ρ = 0.753.
Conclusions
Adding quantitative spatial heterogeneity indicators derived from PET/CT images can improve the prediction of platinum resistance in patients with HGSOC. Spatial heterogeneity indicators were related to Ki‐67 and p53 scores.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
- Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
- School of Health Management, China Medical University, Shenyang, Liaoning, People's Republic of China.
- Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
- Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Förderung
- Science and Technology Foundation of Liaoning Provincial
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Lin, Y., He, D., Sun, M., Xu, L., Chang, Z., Liu, Z., & Li, B. (2024). 18 F ‐Fluoro‐2‐Deoxyglucose Positron Emission Tomography/Computed Tomography Measures of Spatial Heterogeneity for Predicting Platinum Resistance of High‐Grade Serous Ovarian Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.70287
Vancouver
Zhang X, Lin Y, He D, Sun M, Xu L, Chang Z, et al. 18 F ‐Fluoro‐2‐Deoxyglucose Positron Emission Tomography/Computed Tomography Measures of Spatial Heterogeneity for Predicting Platinum Resistance of High‐Grade Serous Ovarian Cancer. Cancer Medicine. 2024. doi:10.1002/cam4.70287
BibTeX
@article{Zhang2024,
author = {Zhang, Xin and Lin, Yuhe and He, Dianning and Sun, Mingli and Xu, Lanlan and Chang, Zhihui and Liu, Zhaoyu and Li, Beibei},
title = {18 F ‐Fluoro‐2‐Deoxyglucose Positron Emission Tomography/Computed Tomography Measures of Spatial Heterogeneity for Predicting Platinum Resistance of High‐Grade Serous Ovarian Cancer},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70287}
}
EUVIMED